UTIPP-Q pilot extended
June 30, 2022
Disclaimer: This article was published in 2022 and reflects the information available at that time. Pharmacists practising in Queensland are advised the UTIPP-Q pilot
Disclaimer: This article was published in 2022 and reflects the information available at that time. Pharmacists practising in Queensland are advised the UTIPP-Q pilot
Disclaimer: This article was published in 2022 and reflects the information available at that time. PDL Professional Officers have observed an increase in formal
Disclaimer: This article was published in 2022 and reflects the information available at that time. PDL representatives Gilbert Yeates (Qld Director) and Gary West
Disclaimer: This article was published in 2022 and reflects the information available at that time. The recent surge in demand for influenza vaccines has
Disclaimer: This article was published in 2022 and reflects the information available at that time. As winter approaches, pharmacies will be very busy providing
Disclaimer: This article was published in 2022 and reflects the information available at that time. All students and interns are registered with AHPRA, and
Disclaimer: This article was published in 2022 and reflects the information available at that time. PDL has previously informed members likely to be working
Disclaimer: This article was published in 2022 and reflects the information available at that time. PDL is aware of multiple instances where a pharmacist
Disclaimer: This article was published in 2022 and reflects the information available at that time. Professional Indemnity insurance (PI insurance or PII) may seem
Disclaimer: This article was published in 2022 and reflects the information available at that time. The ATAGI approval of Moderna Spikevax for the primary
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.